IP CELL

CPB’s emphasis towards innovation is demonstrated by its significant investments in this area to create new technologies that will create FIRST IN CLASS products and services across the entire biotechnology and life science.

The Company recognizes the importance of intellectual property as the primary means of creating value for its shareholders and has created a culture that encourages and rewards and incentives for innovation. CPB has an in-house Intellectual Property Management Department which supports its development of patent applications, files patents, identifies potential new products and markets for its vaccines and pharmaceutical formulations and provides support to its research activities.

CPB is committed to the enhancement and preservation of its own Intellectual Property while respecting the Intellectual Property rights of others.